Skip to content
    INKT stock page

    MiNK Therapeutics, Inc.

    INKT · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 13, 2026

      MiNK Therapeutics Q2 FY26 — Agent 797 Advances in ARDS with Phase 2 Study and International Access Program

      Read the brief

    Browse all US companies on the earnings-call register.